Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer.

Pagan, Eleonora; Ruggeri, Monica; Bianco, Nadia; Bucci, Eraldo Oreste; Graffeo, Rossella; Borner, Markus; Giordano, Monica; Gianni, Lorenzo; Rabaglio, Manuela; Freschi, Andrea; Cretella, Elisabetta; Seles, Elena; Farolfi, Alberto; Simoncini, Edda; Ciccarese, Mariangela; Rauch, Daniel; Favaretto, Adolfo; Honecker, Friedemann; Berardi, Rossana; Franzetti-Pellanda, Alessandra; ... (2024). Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer. (In Press). Breast, 77(103765), p. 103765. Elsevier 10.1016/j.breast.2024.103765

Preview

Text 1-s2.0-S0960977624000961-main.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (1MB) | Preview

PURPOSE

Although younger age has been negatively associated with persistence to adjuvant endocrine therapy (ET), factors contributing to non-persistence remain poorly understood. We assessed factors associated with non-persistence to ET and described the 5-year trajectories of quality of life (QoL) and symptoms in young women (≤40 years) with hormone receptor-positive breast cancer (BC).

METHODS

We retrieved data on clinical characteristics and non-persistence from the medical annual records in the European cohort of the "Helping Ourselves, Helping Others: The Young Women's BC Study" (IBCSG 43-09 HOHO). Women completed surveys at baseline, biannually for three years, and annually for another seven years. Data collection included sociodemographic information, QoL aspects assessed by the Cancer Rehabilitation Evaluation System-Short Form and symptoms assessed by the Breast Cancer Prevention Trial symptom scales. Cox regression models were applied to identify factors associated with non-persistence.

RESULTS

The cumulative risk of interrupting ET within 5 years was 27.7 % (95 % CI, 21.5-35.2). The QoL subscale scores remained stable over 5 years, with slight improvements in the physical subscale. Hot flashes decreased (p < 0.001), while vaginal problems intensified (p < 0.001) over time. Being married without children and having difficulties interacting and communicating with the medical team were significantly associated with non-persistence.

CONCLUSIONS

Discussing the desire to conceive with partnered childless women and establishing a good relationship with the medical team may be important in addressing the non-persistence in young BC survivors. As recent data suggests the safety of pausing ET to conceive, this approach may be a reasonable future option to limit non-persistence.

Interest & Impact

Downloads

0 since deposited on 17 Jul 2024
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item